TY - JOUR KW - Animals KW - Antibodies, Bacterial KW - Clofazimine KW - Immunosuppression KW - leprosy KW - Mice KW - Mycobacterium leprae KW - Rifampin KW - Time Factors AU - Holmes I B AU - Banerjee D K AU - Hilson G R AB -

Continuous dietary administration of rifampin to mice with an established Mycobacterium leprae footpad infection reduced the bacillary solid ratio, with an estimated survival half-life of 5-6 days. In rifampin-treated immunosuppressed animals the survival half-life of solid bacilli, in the absence of host immunity, was 12-13 days. Clofazimine and B1912 produced a significant effect on solid ratio only after a lag period of apparently 100 days. The rate of action was considerably slower than that of rifampin. Intermittent (once monthly) administration of both drugs produced effects similar to those of continuous administration.

BT - Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) C1 - http://www.ncbi.nlm.nih.gov/pubmed/772686?dopt=Abstract DA - 1976 Apr DO - 10.3181/00379727-151-39276 IS - 4 J2 - Proc. Soc. Exp. Biol. Med. LA - eng N2 -

Continuous dietary administration of rifampin to mice with an established Mycobacterium leprae footpad infection reduced the bacillary solid ratio, with an estimated survival half-life of 5-6 days. In rifampin-treated immunosuppressed animals the survival half-life of solid bacilli, in the absence of host immunity, was 12-13 days. Clofazimine and B1912 produced a significant effect on solid ratio only after a lag period of apparently 100 days. The rate of action was considerably slower than that of rifampin. Intermittent (once monthly) administration of both drugs produced effects similar to those of continuous administration.

PY - 1976 SP - 637 EP - 41 T2 - Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) TI - Effect of rifampin, clofazimine, and B1912 on the viability of Mycobacterium leprae in established mouse footpad infection. VL - 151 SN - 0037-9727 ER -